Mckesson Medical-Surgical Inc. Corporate Office recalls BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.
Recalled July 30, 2025 · FDA recall D-0540-2025 · Mckesson Medical-Surgical Inc. Corporate Office
Hazard
CGMP Deviations; potential temperature excursions due to transit delays · FDA Class II
Units
3 Vials
Sold at
Within the U.S - OH, VA, FL.
Description
CGMP Deviations; potential temperature excursions due to transit delays
Product
BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.
Manufacturer(s)
Mckesson Medical-Surgical Inc. Corporate Office
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →